Literature DB >> 9244069

Intermittent claudication should not be treated by surgery.

M J Phillips1, A R Cowan, C D Johnson.   

Abstract

This debate examines the proposition that surgery is unnecessary or obsolete in the management of intermittent claudication. The case for this argument is that many patients have stable disease or respond well to conservative measures, that claudication is an expression of a systemic cardiovascular illness and that surgery can be replaced by endovascular techniques with equal success, and less disadvantage in the event of treatment failure. The case against the motion is that claudication is associated with repeated cycles of ischaemia and reperfusion, and that these contribute to excess cardiovascular mortality states and, furthermore, that surgery is the only option to relieve symptoms for many patients, especially those with distal disease.

Entities:  

Mesh:

Year:  1997        PMID: 9244069      PMCID: PMC2502810     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

1.  Effect of surgery on the systemic inflammatory response to intermittent claudication.

Authors:  N C Hickey; P Gosling; S Baar; C P Shearman; M H Simms
Journal:  Br J Surg       Date:  1990-10       Impact factor: 6.939

2.  Fate in intermittent claudication: outcome and risk factors.

Authors:  R Jelnes; O Gaardsting; K Hougaard Jensen; N Baekgaard; K H Tønnesen; T Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

3.  Fifteen year experience with subcutaneous bypass grafts for lower extremity ischemia.

Authors:  J Eugene; J Goldstone; W S Moore
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

4.  Effect of daily muscular exercise in patients with intermittent claudication.

Authors:  O A Larsen; N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

5.  Infrapopliteal percutaneous transluminal angioplasty: a safe and successful procedure.

Authors:  K Varty; A Bolia; A R Naylor; P R Bell; N J London
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-04       Impact factor: 7.069

6.  The changing workload of a surgical unit with a vascular interest.

Authors:  J S Budd; A Reid; M Thompson; R Sayers; R Naylor; P R Bell
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-02       Impact factor: 7.069

7.  Assessment of pharmacological agents with a hemorheological action.

Authors:  J A Dormandy; A Matrai
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

Review 8.  Femoral-distal bypass with in situ greater saphenous vein. Long-term results using the Mills valvulotome.

Authors:  M C Donaldson; J A Mannick; A D Whittemore
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

9.  Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.

Authors:  R H Grimm; J D Cohen; W M Smith; L Falvo-Gerard; J D Neaton
Journal:  Arch Intern Med       Date:  1985-07

10.  Systemic responses in patients with intermittent claudication after treadmill exercise.

Authors:  A T Edwards; A D Blann; V J Suarez-Mendez; A M Lardi; C N McCollum
Journal:  Br J Surg       Date:  1994-12       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.